UA80821C2 - 7-aryl-3,9-diazabicyclo (3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases - Google Patents

7-aryl-3,9-diazabicyclo (3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases Download PDF

Info

Publication number
UA80821C2
UA80821C2 UA20041109469A UA20041109469A UA80821C2 UA 80821 C2 UA80821 C2 UA 80821C2 UA 20041109469 A UA20041109469 A UA 20041109469A UA 20041109469 A UA20041109469 A UA 20041109469A UA 80821 C2 UA80821 C2 UA 80821C2
Authority
UA
Ukraine
Prior art keywords
phenyl
diazabicyclo
propyl
trifluorophenoxy
acid
Prior art date
Application number
UA20041109469A
Other languages
English (en)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29286070&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA80821(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of UA80821C2 publication Critical patent/UA80821C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995Pyrazines or piperazines forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UA20041109469A 2002-04-29 2003-08-04 7-aryl-3,9-diazabicyclo (3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases UA80821C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0204705 2002-04-29
PCT/EP2003/003721 WO2003093267A1 (en) 2002-04-29 2003-04-08 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases

Publications (1)

Publication Number Publication Date
UA80821C2 true UA80821C2 (en) 2007-11-12

Family

ID=29286070

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20041109469A UA80821C2 (en) 2002-04-29 2003-08-04 7-aryl-3,9-diazabicyclo (3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases

Country Status (26)

Country Link
US (2) US7427613B2 (https=)
EP (1) EP1501830B1 (https=)
JP (1) JP4041123B2 (https=)
KR (1) KR100783863B1 (https=)
CN (1) CN1649870A (https=)
AT (1) ATE527261T1 (https=)
AU (1) AU2003233963B2 (https=)
BR (1) BR0309498A (https=)
CA (1) CA2483241C (https=)
CL (1) CL2003002042A1 (https=)
CO (1) CO5631443A2 (https=)
EC (1) ECSP045378A (https=)
ES (1) ES2372931T3 (https=)
HR (1) HRP20041132A2 (https=)
IL (1) IL164767A0 (https=)
IS (1) IS7545A (https=)
MA (1) MA27305A1 (https=)
MX (1) MXPA04010608A (https=)
NO (1) NO20045042L (https=)
NZ (1) NZ536750A (https=)
PL (1) PL372141A1 (https=)
RU (1) RU2343153C2 (https=)
TW (1) TW200514786A (https=)
UA (1) UA80821C2 (https=)
WO (1) WO2003093267A1 (https=)
ZA (1) ZA200408283B (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096804A1 (en) * 2003-04-28 2004-11-11 Actelion Pharmaceuticals Ltd Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
AU2004233575A1 (en) * 2003-04-30 2004-11-11 Actelion Pharmaceuticals Ltd 9-azabicyclo'3.3.1!non-6-ee derivatives with a heteroatom at the 3-position as renin inhibitors
JP2006524657A (ja) * 2003-04-30 2006-11-02 アクテリオン ファマシューティカルズ リミテッド 新規トロパン誘導体
US20060235044A1 (en) * 2003-04-30 2006-10-19 Olivier Bezencon Azabicyclononene derivatives
JP2006525259A (ja) * 2003-05-02 2006-11-09 アクテリオン ファマシューティカルズ リミテッド 新規ジアザビシクロノネン誘導体
WO2004105762A1 (en) * 2003-05-30 2004-12-09 Actelion Pharmaceuticals Ltd Medical use of diazabicyclononene derivatives as inhibitors of parasite aspartic proteases
CN1863773A (zh) * 2003-10-09 2006-11-15 埃科特莱茵药品有限公司 四氢吡啶衍生物
EP1678176A1 (en) * 2003-10-13 2006-07-12 Actelion Pharmaceuticals Ltd. Diazabicyclononene derivatives and their use as renin inhibitors
CN1930170A (zh) * 2003-10-23 2007-03-14 埃科特莱茵药品有限公司 二氮杂二环壬烯及四氢吡啶衍生物用作肾素抑制剂
WO2005054243A1 (en) * 2003-12-05 2005-06-16 Actelion Pharmaceuticals Ltd Diazabicyclononene derivatives and their use as renin inhibitors
US20070135406A1 (en) * 2003-12-05 2007-06-14 Olivier Bezencon Diazabicyclononene and tetrahydropyridine derivatives with a new side-chain
EP1786814B1 (en) * 2004-08-25 2010-03-31 Actelion Pharmaceuticals Ltd. Bicyclononene derivatives as renin inhibitors
WO2006021403A1 (en) * 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Bicyclononene derivatives
WO2006021401A2 (en) * 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Bicylononene derivatives
WO2006021399A2 (en) * 2004-08-25 2006-03-02 Actelion Pharmaceuticals Ltd Azabicyclononene derivatives as renin inhibitors
AR052263A1 (es) * 2004-12-08 2007-03-07 Actelion Pharmaceuticals Ltd Derivado de diazabiciclononeno
WO2006063610A1 (en) * 2004-12-17 2006-06-22 Actelion Pharmaceuticals Ltd Heteroaryl substituted diazabicyclononene derivatives
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
CA2595986A1 (en) * 2005-01-28 2006-08-03 Actelion Pharmaceuticals Ltd 7-{4-[2-(2,6-dichlor0-4-methylphenoxy)-ethoxy]phenyl}-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amides as inhibitors of renin for the treatment of hypertension
EP1893578A2 (en) * 2005-05-27 2008-03-05 Actelion Pharmaceuticals Ltd. Novel piperidine carboxylic acid amide derivatives
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
JP5306821B2 (ja) 2005-12-30 2013-10-02 ノバルティス アーゲー レニン阻害剤としての3,5−置換ピペリジン化合物
NZ570828A (en) 2006-02-02 2011-07-29 Actelion Pharmaceuticals Ltd Secondary amines as renin inhibitors
AU2007224368A1 (en) * 2006-03-08 2007-09-13 Actelion Pharmaceuticals Ltd New amines
JP2010527942A (ja) 2007-05-24 2010-08-19 メルク フロスト カナダ リミテツド 新規類のレニン阻害剤
NZ582098A (en) 2007-06-25 2012-03-30 Novartis Ag N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
AU2008288648A1 (en) 2007-08-20 2009-02-26 Merck Frosst Canada Ltd. Renin inhibitors
CN102015682B (zh) 2008-05-05 2014-07-16 埃科特莱茵药品有限公司 作为肾素抑制剂的3,4-取代的哌啶衍生物
CN109721613B (zh) * 2017-10-27 2021-07-30 四川科伦博泰生物医药股份有限公司 含季铵离子的大环酰胺化合物及其药物组合物和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509161A (en) 1967-07-10 1970-04-28 Boehringer & Soehne Gmbh 3-phenyl-granatene-(2)-derivatives
GB9020927D0 (en) 1990-09-26 1990-11-07 Beecham Group Plc Pharmaceuticals
US5268361A (en) * 1991-06-07 1993-12-07 Sri International Hydroxyazido derivatives and related compounds as renin inhibitors
US5374719A (en) * 1993-06-04 1994-12-20 Eli Lilly And Company Process for converting loracarbef dihydrate to loracarbef monohydrate
RU2167865C2 (ru) * 1995-09-07 2001-05-27 Ф. Хоффманн-Ля Рош Аг Производные пиперидина, способ их получения, фармацевтическая композиция на их основе и промежуточные вещества
EP0966464B1 (en) 1997-03-03 2003-05-28 Basilea Pharmaceutica AG Substituted 2,4-diaminopyrimidines
US20060223795A1 (en) * 2003-05-02 2006-10-05 Oliver Bezencon Novel diazabicyclononene derivatives
WO2005054243A1 (en) * 2003-12-05 2005-06-16 Actelion Pharmaceuticals Ltd Diazabicyclononene derivatives and their use as renin inhibitors

Also Published As

Publication number Publication date
HRP20041132A2 (en) 2006-07-31
EP1501830A1 (en) 2005-02-02
US20080312242A1 (en) 2008-12-18
CO5631443A2 (es) 2006-04-28
ATE527261T1 (de) 2011-10-15
MXPA04010608A (es) 2004-12-13
IS7545A (is) 2004-11-22
US20050176700A1 (en) 2005-08-11
AU2003233963A1 (en) 2003-11-17
TW200514786A (en) 2005-05-01
KR100783863B1 (ko) 2007-12-10
ECSP045378A (es) 2004-11-26
IL164767A0 (en) 2005-12-18
BR0309498A (pt) 2005-02-15
RU2004134320A (ru) 2005-08-27
RU2343153C2 (ru) 2009-01-10
US7427613B2 (en) 2008-09-23
NO20045042L (no) 2004-11-19
ES2372931T3 (es) 2012-01-27
WO2003093267A1 (en) 2003-11-13
CN1649870A (zh) 2005-08-03
JP4041123B2 (ja) 2008-01-30
EP1501830B1 (en) 2011-10-05
ZA200408283B (en) 2006-05-31
KR20040101546A (ko) 2004-12-02
NZ536750A (en) 2007-02-23
MA27305A1 (fr) 2005-05-02
CA2483241A1 (en) 2003-11-13
PL372141A1 (en) 2005-07-11
AU2003233963B2 (en) 2008-09-11
CL2003002042A1 (es) 2005-02-04
CA2483241C (en) 2011-05-31
JP2005527602A (ja) 2005-09-15

Similar Documents

Publication Publication Date Title
UA80821C2 (en) 7-aryl-3,9-diazabicyclo (3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
TWI436998B (zh) 咪唑并吡啶-2-酮衍生物
EP1223170B1 (en) Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
US10717736B2 (en) Pyrrole amides as alpha V integrin inhibitors
JP2021500330A (ja) Pad阻害剤としてのイミダゾ−ピリジン化合物
EP2379548B1 (en) Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
US20090215778A1 (en) Alpha-substituted Arylmethyl Piperazine Pyrazolo [1,5-alpha]Pyrimidine Amide Derivatives
EA020816B1 (ru) Ингибиторы вирусов flaviviridae
UA72611C2 (uk) Похідні заміщеного піролопіридинону, корисні як інгібітори фосфодіестерази
UA122389C2 (uk) Циклопропіламіни як інгібітори lsd1
KR20040091614A (ko) 1-알킬-1-아조니아비시클로[2.2.2]옥탄 카르바메이트유도체 및 이의 무스카린 수용체 길항제로서의 용도
UA77797C2 (en) Benzothiadiazepine derivatives, a process for preparation thereof and pharmaceutical composition containing them (variants)
JP2008516946A (ja) 置換されたアミノ−ピリミドンおよびそれらの使用
JP7849377B2 (ja) フェンアルキルアミン、並びにこれを作製及び使用する方法
JP2003527429A (ja) プロテアーゼ阻害物質
US6617357B2 (en) Compounds and their use as PDE inhibitors
EP1458679B1 (en) Pyrrolidine derivatives as prostaglandin modulators
US5491142A (en) 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
UA75057C2 (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias, a method for obtaining thereof (variants), pharmaceutical composition based thereon and intermediary compound
KR100636481B1 (ko) 피롤리딘카보닐아미노 환상 디설파이드
CA3178647A1 (en) Substituted tricyclic amides, analogues thereof, and methods using same
CN116731005B (zh) 一种pcsk9小分子蛋白降解剂及其制备方法和应用
CN103339109B (zh) 四氢异喹啉衍生物
CZ20023617A3 (cs) Použití sloučeniny pro výrobu farmaceutického prostředku pro léčení bakteriální infekce
CN107001327A (zh) 晶体(2s)‑3‑[(3s,4s)‑3‑[(1r)‑1‑羟乙基]‑4‑(4‑甲氧基‑3‑{[1‑(5‑甲基吡啶‑2‑基)氮杂环丁‑3‑基]氧基}苯基)‑3‑甲基吡咯烷‑1‑基]‑3‑氧代丙烷‑1,2‑二醇